10X Genomics, Inc. (TXG)
58.18
-0.92
(-1.56%)
USD |
NASDAQ |
Nov 13, 16:00
58.18
0.00 (0.00%)
After-Hours: 19:59
10X Genomics Price : 58.18 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 57.87 | 60.37 | 53.00 | 59.10 | 2.741M |
| Nov 11, 2026 | 66.50 | 68.94 | 61.98 | 62.05 | 1.755M |
| Nov 10, 2026 | 64.11 | 66.16 | 61.42 | 62.90 | 2.474M |
| Nov 09, 2026 | 60.46 | 66.46 | 59.41 | 65.05 | 2.773M |
| Nov 06, 2026 | 57.89 | 61.99 | 55.50 | 59.28 | 4.523M |
| Nov 05, 2026 | 61.64 | 63.40 | 57.19 | 58.06 | 5.969M |
| Nov 04, 2026 | 68.24 | 68.32 | 62.88 | 67.52 | 2.924M |
| Nov 03, 2026 | 63.21 | 66.19 | 62.51 | 65.29 | 2.631M |
| Nov 02, 2026 | 70.31 | 71.00 | 61.24 | 61.63 | 5.174M |
| Oct 30, 2026 | 73.65 | 75.79 | 67.42 | 70.11 | 5.219M |
| Oct 29, 2026 | 82.12 | 84.40 | 80.08 | 81.55 | 1.860M |
| Oct 28, 2026 | 78.93 | 87.82 | 78.25 | 83.62 | 5.047M |
| Oct 27, 2026 | 72.81 | 79.35 | 72.31 | 78.02 | 2.129M |
| Oct 26, 2026 | 70.81 | 74.45 | 70.81 | 72.96 | 1.413M |
| Oct 23, 2026 | 68.94 | 71.83 | 67.52 | 71.55 | 2.228M |
| Oct 22, 2026 | 73.85 | 75.59 | 67.25 | 69.75 | 4.190M |
| Oct 21, 2026 | 70.92 | 77.55 | 70.10 | 75.59 | 3.125M |
| Oct 20, 2026 | 69.52 | 73.40 | 67.53 | 71.46 | 2.861M |
| Oct 19, 2026 | 71.48 | 72.48 | 68.50 | 69.89 | 2.527M |
| Oct 16, 2026 | 71.91 | 73.99 | 67.52 | 69.86 | 3.387M |
| Oct 15, 2026 | 69.35 | 73.74 | 68.57 | 72.39 | 4.317M |
| Oct 14, 2026 | 69.52 | 74.33 | 68.45 | 73.10 | 4.139M |
| Oct 13, 2026 | 74.50 | 74.55 | 71.25 | 71.79 | 4.041M |
| Oct 12, 2026 | 79.18 | 80.47 | 71.61 | 75.19 | 4.080M |
| Oct 09, 2026 | 78.60 | 85.12 | 78.52 | 80.65 | 3.687M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 111.56 |
| Tempus AI, Inc. | 71.56 |
| Intellia Therapeutics, Inc. | 9.705 |
| Personalis, Inc. | 15.70 |
| Alamar Biosciences, Inc. (California) | 30.83 |
Price Related Metrics
| PS Ratio | 12.14 |
| Price to Book Value | 9.128 |
| Price to Free Cash Flow | 80.06 |
| Earnings Yield | -0.89% |
| Market Cap | 7.650B |